SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CuraGen (CRGN)
An SI Board Since March 1998
Posts SubjectMarks Bans Symbol
478 35 0 CRGN
Emcee:  Superhawk Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
403454 Life Sciences and Roche Announce Commercial Launch of Genome Sequencer 20 Synigel bates-10/7/2005
402CRGN completes enrollment for Velafermin PII for prevention of oral mucositis; rtuck-9/28/2005
401Sep. 27 TopoTarget Starts Patient Dosing In PXD101 Phase Ib Study DJ SJim Oravetz-9/27/2005
400CuraGen Repurchases Additional $23.9 M Of Outstanding 2007 Convertible Debt DOW Jim Oravetz-9/21/2005
399TopoTarget, CuraGen Starts Clinical Phase lb Studies DOW JONES NEWSWIRES SeptembJim Oravetz-9/13/2005
398<i> Looking relatively cheap here?</i> Quite possibly. (Though Inigel bates-8/22/2005
397>>NEW HAVEN, Conn., July 28 /PRNewswire-FirstCall/ -- CuraGen Corporation tuck-8/20/2005
396Fast sequencing comes to light nature.com Published online: 31 July 2005; | doi:tnsaf-7/31/2005
395CuraGen Repurchases $39.9 Million of Outstanding 2007 Convertible Debt Monday Junigel bates-7/25/2005
394CuraGen Presents New Preclinical Data on Velafermin at the 17th Annual Internatinigel bates-6/30/2005
3936/19/05 - Companies announce agreement with NCI for PXD101 Angiogenesis WeeklyJim Oravetz-6/20/2005
392[454 and deep sequencing of HIV] >>BRANFORD, Conn., June 9 /PRNewswire-Fituck-6/9/2005
391[Recombinant Semaphorin 6A-1 Ectodomain Inhibits In Vivo Growth Factor and Tumortuck-5/28/2005
390CuraGen and TopoTarget Announce Cooperative Research and Development Agreement wnigel bates-5/12/2005
389CuraGen Announces Executive Management Changes Thursday May 12, 6:30 am ET NEWnigel bates-5/12/2005
388454 Life Sciences and Roche Enter Exclusive World-Wide Agreement for Ultra High-nigel bates-5/12/2005
387CuraGen Reports First Quarter 2005 Results Thursday April 28, 6:30 am ET - - - nigel bates-4/28/2005
386>>NEW HAVEN, Conn., April 17 /PRNewswire-FirstCall/ -- CuraGen Corporationtuck-4/17/2005
385Jonathan Rothberg To Step Down As CEO Of CuraGen DOW JONES NEWSWIRES April 5, 20Jim Oravetz-4/5/2005
384>>Recombinant Human FIZZ3/Resistin Stimulates Lipolysis<< >>Rtuck-2/13/2005
383For me not yet, as I can't get really excited about the lead programs. But keokalani'nui-2/3/2005
382Any feel for when this becomes a buy ? Even with all the convertible thrown in,nigel bates-2/3/2005
381Pretty fast work then, I'd say. Wonder where DNA is on its ADC program; it keokalani'nui-2/3/2005
380>>Anybody know offhand if this is from the SGEN ADCC license?>> NotIcebrg-2/3/2005
379>> CuraGen expects to file an IND and initiate a Phase I clinical trial fokeokalani'nui-2/3/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News